AbCellera Biologics Inc (ABCL)
3.91
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 10:11
AbCellera Biologics Total Assets (Quarterly): 1.488B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.488B |
| September 30, 2023 | 1.512B |
| June 30, 2023 | 1.537B |
| March 31, 2023 | 1.498B |
| December 31, 2022 | 1.541B |
| September 30, 2022 | 1.552B |
| June 30, 2022 | 1.594B |
| March 31, 2022 | 1.592B |
| Date | Value |
|---|---|
| December 31, 2021 | 1.319B |
| September 30, 2021 | 1.173B |
| June 30, 2021 | 1.152B |
| March 31, 2021 | 1.129B |
| December 31, 2020 | 1.006B |
| September 30, 2020 | 142.39M |
| December 31, 2019 | 23.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.49M
Minimum
Dec 2019
1.594B
Maximum
Jun 2022
1.217B
Average
1.488B
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| InMed Pharmaceuticals Inc | 15.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 335.78M |
| Shareholders Equity (Quarterly) | 1.152B |
| Current Ratio | 7.327 |